| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, U.s. Businesses | U.s. President-pharma Business | President, Salix
1 company
Spurr Robert serves as a President, U.s. Businesses at BHC. Across recent SEC filings that breaks down to 0 buys and 5 sells.
Historically, Spurr Robert's trades have earned a strong insider score of 82/100 across 5 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +65.7%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 14, 2022 | BHC Bausch Health Companies Inc. | U.s. President-pharma Business | Sell | 1,595 | $22.19 | $35,393.05 | -1.7% | -59.4% | -66.2% | |
| Mar 15, 2022 | BHC Bausch Health Companies Inc. | U.s. President-pharma Business | Sell | 4,846 | $22.20 | $107,581.20 | -5.0% | -65.5% | -65.3% | |
| Mar 2, 2022 | BHC Bausch Health Companies Inc. | U.s. President-pharma Business | Sell | 1,595 | $23.37 | $37,275.15 | -2.4% | -59.8% | -61.7% | |
| Feb 15, 2022 | BHC Bausch Health Companies Inc. | U.s. President-pharma Business | Sell | 3,251 | $25.02 | $81,340.02 | -5.1% | -57.8% | -64.8% | |
| Jan 18, 2022 | BHC Bausch Health Companies Inc. | U.s. President-pharma Business | Sell | 3,251 | $26.63 | $86,574.13 | -4.9% | -21.0% | -70.3% |